BDBM574006 9,9'-[(5S,7R,8R,12aR,14R,15R,15aS)- 2,10,15-trihydroxy-2,10- dioxidooctahydro-12H-5,8- methanofuro[3,2-l][1,3,6,9,11,2,10] pentaoxaciphosphacyclotetradecine-7,14- diyl]bis(1,9-dihydro-6H-purin-6-one::US11453697, Example 333

SMILES NC1NC=Nc2c1ncn2[C@@H]1O[C@@H]2COP(O)(=O)O[C@@H]3C[C@@H](COP(O)(=O)O[C@H]2[C@H]1O)O[C@H]3n1cnc2c1nc[nH]c2=O

InChI Key InChIKey=BSEQAAINUOOWSZ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 574006   

LigandPNGBDBM574006(US11453697, Example 333 | 9,9'-[(5S,7R,8R,12aR,14R...)
Affinity DataEC50:  45.9nMAssay Description:The compounds were serially titrated by the Hamilton STARPlus CORE in a 96-well plate (Greiner, #651201) using a 1:3 ten-point dose response format. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
Go to US Patent